Fischer Financial Services Inc. Invests $1.46 Million in Stryker Corporation $SYK

Key Points

• Fischer Financial Services acquired 4,621 shares of Stryker worth approximately $1.46 million, making the medical technology company 0.4% of its portfolio. Institutional investors collectively own 77.09% of Stryker.
• Stryker beat quarterly earnings expectations with EPS of $3.69 versus the $3.49 consensus, while revenue rose 9.4% year over year to $6.59 billion. The company reaffirmed fiscal 2026 EPS guidance of $14.95–$15.10.
• Stryker declared a quarterly dividend of $0.88 per share, equivalent to a $3.52 annualized payout and a 1.1% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $386.28.

Fischer Financial Services Inc. acquired a new stake in Stryker Corporation (NYSE:SYK - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 4,621 shares of the medical technology company's stock, valued at approximately $1,455,000. Stryker comprises 0.4% of Fischer Financial Services Inc.'s investment portfolio, making the stock its 29th largest holding.

A number of other large investors have also recently bought and sold shares of SYK. Vanguard Group Inc. boosted its position in Stryker by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 33,907,291 shares of the medical technology company's stock worth $11,917,396,000 after purchasing an additional 133,892 shares during the period. State Street Corp raised its position in shares of Stryker by 2.1% in the fourth quarter. State Street Corp now owns 15,254,407 shares of the medical technology company's stock valued at $5,374,731,000 after purchasing an additional 311,507 shares during the period. Geode Capital Management LLC raised its position in shares of Stryker by 0.9% in the fourth quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company's stock valued at $2,636,238,000 after purchasing an additional 69,851 shares during the period. Wellington Management Group LLP lifted its stake in shares of Stryker by 22.6% in the fourth quarter. Wellington Management Group LLP now owns 6,493,276 shares of the medical technology company's stock worth $2,282,192,000 after buying an additional 1,198,665 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Stryker in the fourth quarter worth $1,822,272,000. 77.09% of the stock is currently owned by institutional investors.

Stryker Price Performance

NYSE:SYK opened at $327.97 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. Stryker Corporation has a one year low of $281.00 and a one year high of $396.86. The company has a fifty day moving average price of $326.64 and a 200 day moving average price of $332.66. The stock has a market cap of $125.80 billion, a P/E ratio of 33.99, a PEG ratio of 2.17 and a beta of 0.76.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The company had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same quarter in the previous year, the firm posted $3.13 EPS. The business's revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker's payout ratio is currently 36.48%.

Insider Buying and Selling at Stryker

In other Stryker news, insider Debra King sold 826 shares of the company's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the transaction, the insider owned 6,210 shares of the company's stock, valued at $2,088,423. This represents a 11.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Robert S. Fletcher sold 4,544 shares of the firm's stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the sale, the vice president owned 10,582 shares of the company's stock, valued at $3,247,298.34. This represents a 30.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 665,370 shares of company stock valued at $216,238,501 in the last quarter. Corporate insiders own 4.60% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on SYK shares. Leerink Partners lowered their target price on shares of Stryker from $410.00 to $407.00 and set an "outperform" rating on the stock in a research note on Friday, June 5th. Robert W. Baird set a $385.00 target price on shares of Stryker in a research report on Friday, May 1st. Wells Fargo & Company decreased their price target on shares of Stryker from $456.00 to $418.00 and set an "overweight" rating for the company in a report on Friday, May 1st. JPMorgan Chase & Co. lowered their price target on Stryker from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Friday, July 31st. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Stryker in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Stryker has an average rating of "Moderate Buy" and a consensus price target of $386.28.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source